Skip navigation Wisconsin State Legislature
This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
Report received from Agency, January 31, 2023.
Referred to the committee on Universities and Revenue, February 14, 2023.
Senate Clearinghouse Rule 22-052
Relating to the processes for complaints and requests for advice.
Submitted by the Ethics Commission.
Report received from Agency, January 31, 2023.
Referred to the committee on Government Operations, Elections and Consumer Protection, February 14, 2023.
Senate Clearinghouse Rule 22-056
Relating to Wisconsin Fast Forward Workforce Training Grants.
Submitted by the Department of Workforce Development.
Report received from Agency, January 31, 2023.
Referred to the committee on Labor, Regulatory Reform, Veterans and Military Affairs, February 14, 2023.
Senate Clearinghouse Rule 22-084
Relating to qualified residential treatment programs.
Submitted by the Department of Children and Families.
Report received from Agency, January 30, 2023.
Referred to the committee on Health, February 14, 2023.
_____________
The committee on Health reported and recommended:
Senate Clearinghouse Rule 20-053
Relating to continuing medical education for physicians.
No action taken on February 14, 2023.
Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Senate Clearinghouse Rule 21-016
Relating to telehealth.
No action taken on February 14, 2023.
Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Senate Clearinghouse Rule 21-033
Relating to telehealth.
No action taken on February 14, 2023.
Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Senate Clearinghouse Rule 21-074
Relating to name and address change, floor design, procedures for disciplinary proceedings, superseded references, and technical correction.
No action taken on February 14, 2023.
Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Senate Clearinghouse Rule 21-086
Relating to requirements for class III permits for anesthesia.
No action taken on February 14, 2023.
Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Senate Clearinghouse Rule 22-011
Relating to scheduling Crotonyl Fentanyl.
No action taken on February 14, 2023.
Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Senate Clearinghouse Rule 22-014
Relating to scheduling Remimazolam.
No action taken on February 14, 2023.
Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Senate Clearinghouse Rule 22-015
Relating to radiation protection requirements for radiation-producing machines and radioactive materials.
No action taken on February 14, 2023.
Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Senate Clearinghouse Rule 22-016
Relating to scheduling Brorphine.
No action taken on February 14, 2023.
Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Senate Clearinghouse Rule 22-019
Relating to service fund for people who are deaf, deafblind or hard of hearing.
No action taken on February 14, 2023.
Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Senate Clearinghouse Rule 22-026
Relating to long-term care services and Medical Assistance fair hearing process.
No action taken on February 14, 2023.
Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Senate Clearinghouse Rule 22-032
Relating to scheduling Serdexmethylphenidate.
No action taken on February 14, 2023.
Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Senate Clearinghouse Rule 22-033
Relating to scheduling ten (10) fentanyl related substances.
No action taken on February 14, 2023.
Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Senate Clearinghouse Rule 22-034
Relating to scheduling Alfaxalone.
No action taken on February 14, 2023.
Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Senate Clearinghouse Rule 22-035
Relating to Excluding 6-beta-Naltrexol.
No action taken on February 14, 2023.
Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Senate Clearinghouse Rule 22-036
Relating to scheduling Fospropofol.
No action taken on February 14, 2023.
Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Senate Clearinghouse Rule 22-037
Relating to scheduling Embutramide.
No action taken on February 14, 2023.
Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Senate Clearinghouse Rule 22-038
Relating to scheduling Perampanel.
Loading...
Loading...